Markers to predict macrocyclic lactone drug resistance in Dirofilaria immitis, the causative agent of heartworm disease
US11414703B2 · kind B2 · utility
0Cited by
4References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 2, 2018 |
| Grant date | Aug 16, 2022 |
| Priority date | — |
| Expiry date | Feb 2, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Disclosed are nucleic acid molecules from the genome of Dirofilaria spp. nematodes that contain single nucleotide polymorphisms related to reduced responsiveness of the nematodes to macrocyclic lactones. In one example, the species of Dirofilaria is Dirofilaria immitis (the agent of heartworm in animals). Also disclosed are methods for determining the responsiveness of Dirofilaria spp. nematodes to macrocyclic lactones, methods for selecting a treatment to treat an animal infected with a Dirofilaria spp. nematode, and kits for determining the responsiveness of Dirofilaria spp. nematodes to macrocyclic lactones.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.